Company: Cipla Ltd.
Generic Drug: Sodium Cromoglycate (Mast Cell Stabilizer)
Indication: Prophylactic therapy of bronchial asthma and prevention of exercise induced asthma.
Contraindication: Hypersensitivity to any component in preparation.
Dosage & Administration: Available as suspension for inhalation through nebulizer.
- Cautious use during lactation and pregnancy
- Cautious use in cardiac arrhythmias, hepatic or renal dysfunction.
Side effects/ Undesired effects/ Adverse drug reactions: Nausea, headache, dryness of mouth, unpleasant taste, bronchospasm, wheezing, nasal congestion, cough and throat irritation.